BSX vs COO: fair value comparison
Boston Scientific Corporation and The Cooper Companies, Inc. · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, BSX currently sits closer to the top of our discount ranking. BSX carries the stronger quality grade.
| BSX | COO | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $42.98 | $53.91 |
| 12-month range | $46.73–$101.01 | $60.19–$83.92 |
| Sector rank | #6 of 113 Healthcare | #7 of 113 Healthcare |
| Quality grade | A | B |
| Leverage | Moderate | Low |
| Margin trend | Expanding | Contracting |
| Revenue growth | Strong | Modest |
| RSI zone | Oversold | Oversold |
| 50/200-day trend | — | Downtrend |
| DCF cross-check | Undervalued | — |
| 52-week position | The bottom quarter | The bottom quarter |
Full single-stock breakdowns: BSX fair value analysis · COO fair value analysis